Cerdulatinib
- Generic Name
- Cerdulatinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H27N7O3S
- CAS Number
- 1198300-79-6
- Unique Ingredient Identifier
- D1LXQ45S1O
- Background
Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath